Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-17 9:05 pm Unchanged |
2023-10-17 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Life Science Opportunities Fund VI | 1,211,262 0.500% |
0 (Unchanged) |
Filing History |
| 2023-10-16 8:56 pm Unchanged |
2023-10-07 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Life Science Opportunities Fund VI | 1,211,262 0.500% |
0 (Unchanged) |
Filing History |
| 2023-06-07 9:44 pm Sale |
2023-06-07 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Life Science Opportunities Fund VI | 1,211,262 10.900% |
-60,913 (-4.79%) |
Filing History |
| 2023-05-22 07:04 am Sale |
2023-05-18 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Life Science Opportunities Fund VI | 1,272,175 12.200% |
-551,815 (-30.25%) |
Filing History |
| 2021-04-27 9:45 pm Purchase |
2021-04-26 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Life Science Opportunities Fund VI | 1,823,990 19.200% |
616,817 (+51.10%) |
Filing History |
| 2021-02-11 10:59 am Purchase |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Puissance Life Science Opportunities Fund VI | 255,718 2.340% |
255,718 (New Position) |
Filing History |
| 2020-05-22 07:38 am Purchase |
2020-05-21 | 13D | Bellerophon Therapeutics, Inc. BLPH |
Puissance Life Science Opportunities Fund VI | 1,207,173 13.100% |
1,207,173 (New Position) |
Filing History |